Table 2.
Baseline characteristics
| STEMI (n = 138) | BV‐STE (n = 196) | p | |
|---|---|---|---|
| Age, years | 58 (14) | 31 (5) | <0.001 |
| Male, n (%) | 101 (73) | 191 (97) | <0.001 |
| White, n (%) | 138 (100) | 196 (100) | 1.0 |
| Hypertension, n (%) | 67 (48) | 14 (7) | <0.001 |
| Diabetes, n (%) | 50 (36) | 5 (3) | <0.001 |
| Tobacco use, n (%) | 65 (47) | 32 (16) | <0.001 |
| Prior MI, n (%) | 20 (14) | 1 (1) | <0.001 |
| Prior PCI, n (%) | 20 (14) | 0 (0) | <0.001 |
| Prior CABG, n (%) | 3 (2) | 0 (0) | 0.038 |
| Heart rate, bpm | 82 (16) | 76 (13) | <0.001 |
| SBP, mmHg | 145 (26) | 129 (15) | <0.001 |
BV‐STE: benign variant ST‐segment elevation; CABG: coronary artery by‐pass grafting; MI: myocardial infarction; PCI: percutaneous coronary intervention; SBP: systolic blood pressure; STEMI: ST‐segment elevation myocardial infarction.